AMEX:CPHI

CPHI to Hold Second Quarter 2018 Earnings Conference Call on Wednesday August 15, 2018 at 8:30 a.m. ET

HAIKOU, China, Aug. 6, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its second quarter 2018 earnings conference...

2018-08-06 20:45 605

China Pharma Holdings, Inc. Reports First Quarter 2018 Financial Results

HAIKOU, China, May 15, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ended...

2018-05-15 18:00 829

CPHI to Hold First Quarter 2018 Earnings Conference Call On Tuesday May 15, 2018 at 8:30 a.m. ET

HAIKOU, China, May 8, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its first quarter 2018 earnings conference c...

2018-05-08 20:00 712

China Pharma Holdings, Inc. Reports Fiscal Year 2017 Financial Results

HAIKOU, China, April 3, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the fiscal year ...

2018-04-03 18:00 413

CPHI to Hold Fiscal Year 2017 Earnings Conference Call On Tuesday April 3, 2018 at 8:30 a.m. ET

HAIKOU CITY, China, March 22, 2018 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its  fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its fiscal year 2017 earnings confe...

2018-03-22 20:00 421

China Pharma Holdings, Inc. Reports Third Quarter 2017 Financial Results

HAIKOU CITY, China, Nov. 15, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...

2017-11-15 19:00 572

CPHI to Hold Third Quarter 2017 Earnings Conference Call On Wednesday November 15, 2017 at 8:30 a.m. ET

HAIKOU CITY, China, Nov. 7, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its  fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its third quarter 2017 earnings confe...

2017-11-07 21:00 473

China Pharma Holdings, Inc. Announces Notification of NYSE American Listing Deficiency

HAIKOU, China, Sept. 12, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) (the "Company") today announced receipt of notification (the "Deficiency Letter") from the NYSE AMERICAN LLC ("NYSE American") that the Company is not in compliance with certain NYSE American continued...

2017-09-13 04:05 1032

China Pharma Holdings, Inc. Reports Second Quarter 2017 Financial Results

HAIKOU CITY, China, Aug. 15, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE American listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter...

2017-08-15 18:00 1553

CPHI to Hold Second Quarter 2017 Earnings Conference Call On Tuesday August 15, 2017 at 8:30 a.m. ET

HAIKOU CITY, China, Aug. 8, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its second quarter 2017 earnings confe...

2017-08-08 18:00 1645

China Pharma Holdings, Inc.'s Wholly-owned Subsidiary Participated in PharmChina/API China Conferences

HAIKOU, China, May 17, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma," the "Company" or "We"), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced its wholly-owned subsidiary, Hainan Helpso...

2017-05-17 20:30 1744

China Pharma Holdings, Inc. Reports First Quarter 2017 Financial Results

HAIKOU CITY, China, May 12, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE MKT: CPHI) ("China Pharma,"  the "Company" or "We"), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced financial results for the quarter ...

2017-05-12 18:00 3708

CPHI to Hold First Quarter 2017 Earnings Conference Call On Friday May 12, 2017 at 8:30 a.m. ET

HAIKOU CITY, China, May 8, 2017 /PRNewswire/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE MKT: CPHI), an NYSE MKT listed corporation with its fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it plans to hold its first quarter 2017 earnings confere...

2017-05-08 18:00 1741

China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity

HAIKOU, China, June 17, 2011 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced that, in view of the unusual market activity in the common stock of China Pharma, the NYSE...

2011-06-17 03:55 1060

China Pharma Holdings, Inc. to Present at the Eighth Annual Piper Jaffray China Growth Conference in New York on May 17, 2011

HAIKOU, China, May 13, 2011 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a leading fully-integrated specialty pharmaceutical company in China, today announced that the Company's Chief Financial Officer, Mr. Frank Waung, has been invited to pre...

2011-05-13 08:00 1244

China Pharma Holdings, Inc. Reports First Quarter 2011 Financial Results

HAIKOU CITY, China, May 11, 2011 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the quarter ended March 31, 2011. First Quarter 2011 Highlights...

2011-05-11 19:30 1708

China Pharma Holdings, Inc. to Report First Quarter of Fiscal Year 2011 Financial Results on May 11, 2011

HAIKOU CITY, China, May 6, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release first quarter of year 2011 financial results b...

2011-05-06 20:00 1177

China Pharma Holdings, Inc. Reports Full Year 2010 Financial Results

HAIKOU CITY, China, March 3, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE Amex: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals company in China, today announced financial results for the year ended December 31, 2010. Full Year Highligh...

2011-03-03 19:15 1422

China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011

HAIKOU, China, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its fiscal year 2010 financial results before the...

2011-02-25 21:00 886

China Pharma Holdings, Inc. Announces Successful Completion of Clinical Trials of the Cholesterol-Lowering Drug, Rosuvastatin

HAIKOU CITY, China, Dec. 6, 2010 /PRNewswire-Asia/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced the completion of clinical trials of the cholesterol-lowering drug, rosuvastatin...

2010-12-06 21:00 1039